One molecule’s journey from discovery to market
With the help of outsourcing partners, the small biotech firm Nabriva brought lefamulin to patients by itself. Now it needs to make a profit in the tough-to-crack antibiotic business
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
June 22, 2020 Cover
Volume 98, Issue 24
With the help of outsourcing partners, the small biotech firm Nabriva brought lefamulin to patients by itself. Now it needs to make a profit in the tough-to-crack antibiotic business
Volume 98 |
Issue 24
Drug Development
Strongly correlated materials could enable new applications in computing, sensing, and infrared camouflage
Vanadium dioxide and samarium nickel oxide transform from insulators to metals and back when triggered by heat, light, or other stimuli
Plastics during the pandemic
COVID-19 has meant a shift in plastics markets, and polymer makers are hustling to keep up
-
Former US Chemical Safety Board member Kristen Kulinowski reflects on her term
She is ‘bullish’ on the board’s future despite history of turmoil
-
What you need to know to get back to the lab amid the COVID-19 pandemic
Managing expectations will be key, says Jen Heemstra
-
ADVERTISEMENT
Science Concentrates
Dexamethasone appears to help severe cases of COVID-19
The inexpensive, well-studied steroid could give doctors another tool in the coronavirus pandemic
Business & Policy Concentrates
- COVID-19 vaccines and antibodies advance even faster than expected
- ChemSec hands out sustainability report cards to industry
- Podcast: TSCA was reformed 4 years ago. Is the US chemical law living up to expectations?
- Perchlorate in drinking water doesn’t need US federal limits, EPA says
- Firms explore greener ethylene
